Document is current

Article History

Accepted: 26 November 2024

First Online: 20 March 2025

Declarations

:

: This article has been published as part of a journal supplement wholly funded by Avadel Pharmaceuticals (Chesterfield, MO, USA). The development of this manuscript was funded by Avadel Pharmaceuticals. Open access publication and publication costs were funded by Avadel Pharmaceuticals.

: A.M.M. has served as a consultant, speaker, and/or on advisory boards for Avadel Pharmaceuticals, Eisai, Harmony Biosciences, Jazz Pharmaceuticals, Alkermes, and Takeda Pharmaceutical Co; has received grant funding from National Institutes of Health, UCB Pharmaceuticals, Jazz Pharmaceuticals, ResMed Foundation, Coverys Foundation, Harmony Biosciences, and Geisinger Health Plan; is the CEO of DAMM Good Sleep, LLC; and serves as an advisor for Neura Health and Floraworks. S.K. has no disclosures to report at this time. S.H. has served as a speaker for Jazz Pharmaceuticals. She is on the advisory board of Wake Up Narcolepsy and Project Sleep and is the founder of NY Sleep and Psychology. M.G. is cofounder and executive director of Wake Up Narcolepsy, nonprofit 501c3 organization. The organization has received grant funding for narcolepsy educational and awareness initiatives from Avadel Pharmaceuticals, Axsome Therapeutics, Harmony Biosciences, Jazz Pharmaceuticals, Takeda Pharmaceuticals, and Alkermes.

: Not applicable.

: Not applicable.

: Not applicable.

: Data sharing is not applicable to this article as no datasets were generated or analyzed.

: Not applicable.

: A.M.M., S.Y.K., S.H., and M.G. were involved in the conceptualization, analysis of existing literature and data, and drafting/critically revising the manuscript. All authors have read and approved the final submitted manuscript and agree to be accountable for the work.